336 related articles for article (PubMed ID: 28230785)
1. The Application of a Modified d-ROMs Test for Measurement of Oxidative Stress and Oxidized High-Density Lipoprotein.
Ito F; Ito T; Suzuki C; Yahata T; Ikeda K; Hamaoka K
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230785
[TBL] [Abstract][Full Text] [Related]
2. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel high-density lipoprotein antioxidant capacity assay and its application to high-density lipoprotein fractions.
Gaál K; Lőrincz H; Seres I; Harangi M; Oláh AV; Paragh G
Clin Biochem; 2013 Jun; 46(9):825-7. PubMed ID: 23353781
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoproteins prevent the oxidized low-density lipoprotein-induced epidermal [corrected] growth factor receptor activation and subsequent matrix metalloproteinase-2 upregulation.
Robbesyn F; Augé N; Vindis C; Cantero AV; Barbaras R; Negre-Salvayre A; Salvayre R
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1206-12. PubMed ID: 15817880
[TBL] [Abstract][Full Text] [Related]
5. Identification of molecular species of oxidized triglyceride in plasma and its distribution in lipoproteins.
Shrestha R; Hui SP; Miura Y; Yagi A; Takahashi Y; Takeda S; Fuda H; Chiba H
Clin Chem Lab Med; 2015 Oct; 53(11):1859-69. PubMed ID: 25781693
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody.
Nakano T; Nagata A
J Lab Clin Med; 2003 Jun; 141(6):378-84. PubMed ID: 12819635
[TBL] [Abstract][Full Text] [Related]
7. Oxidized HDL induces cytotoxic effects: implications for atherogenic mechanism.
Soumyarani VS; Jayakumari N
J Biochem Mol Toxicol; 2014 Nov; 28(11):481-9. PubMed ID: 25044446
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein antagonizes oxidized low-density lipoprotein by suppressing oxygen free-radical formation and preserving nitric oxide bioactivity.
Lee CM; Chien CT; Chang PY; Hsieh MY; Jui HY; Liau CS; Hsu SM; Lee YT
Atherosclerosis; 2005 Dec; 183(2):251-8. PubMed ID: 16098532
[TBL] [Abstract][Full Text] [Related]
10. Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia.
Hsu HC; Lee YT; Yeh HT; Chen MF
J Lab Clin Med; 2001 Jun; 137(6):414-21. PubMed ID: 11385362
[TBL] [Abstract][Full Text] [Related]
11. Correlation between reactive oxygen metabolites & atherosclerotic risk factors in patients with type 2 diabetes mellitus.
Kotani K; Tsuzaki K; Taniguchi N; Sakane N
Indian J Med Res; 2013 Apr; 137(4):742-8. PubMed ID: 23703342
[TBL] [Abstract][Full Text] [Related]
12. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of oxidative stress in patients with hyperlipidemia.
Araujo FB; Barbosa DS; Hsin CY; Maranhão RC; Abdalla DS
Atherosclerosis; 1995 Sep; 117(1):61-71. PubMed ID: 8546756
[TBL] [Abstract][Full Text] [Related]
14. Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia.
Bai H; Liu BW; Deng ZY; Shen T; Fang DZ; Zhao YH; Liu Y
Free Radic Biol Med; 2006 May; 40(10):1796-803. PubMed ID: 16678017
[TBL] [Abstract][Full Text] [Related]
15. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral contraceptives on lipid metabolism.
Krauss RM
J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, d-ROMs test, and ceruloplasmin.
Colombini F; Carratelli M; Alberti A
Free Radic Res; 2016; 50(4):447-53. PubMed ID: 26729560
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
Malle E; Marsche G; Panzenboeck U; Sattler W
Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
[TBL] [Abstract][Full Text] [Related]
19. The two faces of α- and γ-tocopherols: an in vitro and ex vivo investigation into VLDL, LDL and HDL oxidation.
Nadeem N; Woodside JV; Kelly S; Allister R; Young IS; McEneny J
J Nutr Biochem; 2012 Jul; 23(7):845-51. PubMed ID: 21715151
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic analysis of polar metabolites in lipoprotein fractions identifies lipoprotein-specific metabolic profiles and their association with insulin resistance.
Hyötyläinen T; Mattila I; Wiedmer SK; Koivuniemi A; Taskinen MR; Yki-Järvinen H; Orešič M
Mol Biosyst; 2012 Oct; 8(10):2559-65. PubMed ID: 22722885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
